[January 5, 2022] Scintica is excited to announce its new and extended distribution agreement for preclinical products with Aspect Imaging, global leader in innovative, high-performance permanent magnet MRI technology.
Aspect imaging has been pushing the boundaries of permanent magnet design to deliver easy-to-use MR imaging solutions for both clinical and preclinical market segments. The updated agreement between Scintica and Aspect Imaging will have Scintica exclusively handling all sales and marketing activities for the preclinical M-series products world-wide. The M-Series of products has been specifically designed for use on preclinical animal models, including mice, rats, non-human primates, and similarly sized species. Each system features a unique self-shielded design, enabling it to be conveniently placed in almost any location, without the limitations of infrastructure requirements associated with superconducting MRI systems.
Scintica is a value-added reseller of advanced preclinical research instrumentation with locations in Canada, the USA, and Europe. Their team of scientists on staff has the depth of experience to guide scientists in real-world applications of the equipment and provide the training and support to help customers get results.
With a proven track record of bringing the M-Series technology to the North American market, Scintica will expand this responsibility to sell directly and work with established distributors worldwide, to bring this revolutionary technology to researchers around the world in a wide variety of application areas.
“We see the Aspect MRI systems as a means to make high-value MRI technology available to a majority of scientists at a reasonable cost and without the traditional infrastructure issues” said Blair Poetschke, President of Scintica. “Taking full responsibility for the preclinical division sales, marketing, and support efforts will allow us to provide a seamless global approach and enable many exciting research applications for the future.”
Guy Cohen, Aspect Imaging’s VP of Research and Development, and Site Manager in Israel, said “Partnering with Scintica will provide Aspect Imaging a clear visibility into the global preclinical market. It will increase our ability to focus on customers’ needs and speed up the development of our preclinical M-Series™ MRI products.”
The M-Series™ Systems are compact, self-shielded, high-performance MRI systems. The M-Series allow preclinical researchers, with or without in-depth knowledge of MR physics, to utilize the gold standard method of soft tissue imaging without the cost, complexity, and technical burden on conventional MRI systems. Now, with the support of Scintica, more researchers around the world will learn about these innovative systems.
For more information about these systems please visit www.scintica.com/products/aspect-imaging/m-series-compact-mri/
About Aspect Imaging
Aspect Imaging is a global leader in innovative, high-performance compact MR imaging solutions. Its unique systems feature a self-shielded design, enables it to be conveniently placed in almost any location – without the limitations of infrastructure requirements associated with superconducting MRI systems.
Scintica is a value-added reseller of advanced preclinical research instrumentation with locations in Canada, the USA, and Europe. Scintica carries a diverse but synergistic portfolio of products, encouraging a holistic approach to science, ranging from imaging systems, to laboratory tools and equipment for both in vitro and in vivo studies. monitoring. For more information, please contact us at firstname.lastname@example.org or visit www.scintica.com.
Contact info (Aspect)*:
Contact info (Scintica)
Tel: +1 (519) 914 5495